Myotilinopathy: refining the clinical and myopathological phenotype.


Mutations in myotilin gene (MYOT) have been associated with variable syndromes including limb girdle muscular dystrophy type 1A (LGMD1A) and a subgroup of myofibrillar myopathy (MFM/MYOT). We studied six Spanish patients from three unrelated kindreds and seven patients without family history. Three previously reported and two novel disease-associated MYOT mutations were identified in this group of patients. The disease is characterized by the onset at the age of 42-77 years with muscle weakness initially in distal or proximal leg muscles, eventually spreading to other muscle groups of the lower and upper extremities. Associated signs of cardiomyopathy, respiratory failure and peripheral neuropathy are present in a fraction of patients. Myopathological features of focal myofibrillar destruction resulting in intracytoplasmic deposits, strongly immunoreactive to myotilin, multiple rimmed and centrally or subsarcolemmally located non-rimmed vacuoles and streaming Z-lines, were observed in each patient studied. The Spanish cohort, the largest group of patients studied so far, shares phenotypic features with both LGMD1A and MFM/MYOT variants thus establishing a continuum of phenotypic manifestations characteristic of myotilinopathy, an emerging neuromuscular disorder.

Extracted Key Phrases

10 Figures and Tables

Citations per Year

1,659 Citations

Semantic Scholar estimates that this publication has 1,659 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Oliv2005MyotilinopathyRT, title={Myotilinopathy: refining the clinical and myopathological phenotype.}, author={Montse Oliv{\'e} and Lev G. Goldfarb and Alexey Shatunov and Dirk Fischer and Isidro Ferrer}, journal={Brain : a journal of neurology}, year={2005}, volume={128 Pt 10}, pages={2315-26} }